SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-027639
Filing Date
2022-05-17
Accepted
2022-05-17 16:05:37
Documents
17
Period of Report
2022-05-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea160174-8k_biotech.htm   iXBRL 8-K 43276
2 PRESS RELEASE ea160174ex99-1_biotech.htm EX-99.1 29749
7 GRAPHIC image_001.jpg GRAPHIC 3019
8 GRAPHIC image_002.jpg GRAPHIC 2241
9 GRAPHIC image_003.gif GRAPHIC 1827
  Complete submission text file 0001213900-22-027639.txt   324226

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE biot-20220517.xsd EX-101.SCH 4048
4 XBRL DEFINITION FILE biot-20220517_def.xml EX-101.DEF 27210
5 XBRL LABEL FILE biot-20220517_lab.xml EX-101.LAB 37714
6 XBRL PRESENTATION FILE biot-20220517_pre.xml EX-101.PRE 25830
11 EXTRACTED XBRL INSTANCE DOCUMENT ea160174-8k_biotech_htm.xml XML 6993
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 22934453
SIC: 2834 Pharmaceutical Preparations